Free. Unsubscribe any time.
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 10 transactions and 310,520 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-11, came 79 days after the one before it (2026-06-24) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 8,750 shares, 16,250 fewer than the 25,000 in the filing before it.
- Its 10 plan statements rank 385th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 5 have more plan statements on file than it and 5 have fewer.
- Its 10 filings on file run from 2025-09-08 to 2026-09-11, and state no plan adoption date.
Trades in Aquestive Therapeutics, Inc. 10
- Jung Cassie — 2025-09-04 · S · 62,180 shares
- Boyd Peter E. — 2025-09-05 · S · 15,000 shares
- Barber Daniel — 2025-09-19 · S · 400 shares
- Barber Daniel — 2025-09-26 · S · 91,343 shares
- Boyd Peter E. — 2025-09-26 · S · 10,000 shares
- Boyd Peter E. — 2025-10-15 · S · 10,000 shares
- Jung Cassie — 2025-10-15 · S · 67,575 shares
- Kraus Carl N — 2025-10-15 · S · 20,272 shares
- Krop Julie — 2026-06-23 · S · 25,000 shares
- Korczynski Sherry — 2026-09-09 · S · 8,750 shares
Adoption dates in Aquestive Therapeutics, Inc. 0
Results prints in Aquestive Therapeutics, Inc. 8
- 2025-01-13
- 2025-03-05
- 2025-05-12
- 2025-08-11
- 2025-11-05
- 2026-03-04
- 2026-05-13
- 2026-08-11
Trades before a print in Aquestive Therapeutics, Inc. 0
- 21 days before the 2025-11-05 print — 2025-10-15 · S · Boyd Peter E. · 10,000 shares
- 21 days before the 2025-11-05 print — 2025-10-15 · S · Jung Cassie · 67,575 shares
- 21 days before the 2025-11-05 print — 2025-10-15 · S · Kraus Carl N · 20,272 shares
- 40 days before the 2025-11-05 print — 2025-09-26 · S · Barber Daniel · 91,343 shares
- 40 days before the 2025-11-05 print — 2025-09-26 · S · Boyd Peter E. · 10,000 shares
- 47 days before the 2025-11-05 print — 2025-09-19 · S · Barber Daniel · 400 shares
- 49 days before the 2026-08-11 print — 2026-06-23 · S · Krop Julie · 25,000 shares
- 61 days before the 2025-11-05 print — 2025-09-05 · S · Boyd Peter E. · 15,000 shares
- 62 days before the 2025-11-05 print — 2025-09-04 · S · Jung Cassie · 62,180 shares
Interval to Aquestive Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 21shortest, days
- 1no later print
Reported results dates on file
- 2025-01-13
- 2025-03-05
- 2025-05-12
- 2025-08-11
- 2025-11-05
- 2026-03-04
- 2026-05-13
- 2026-08-11
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.